Trial Profile
A phase IV study assessing the safety and efficacy of Veltassa (patiromer) in patients with resistant hypertension
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Patiromer (Primary)
- Indications Hyperkalaemia
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record